{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:44:40Z","timestamp":1785793480742,"version":"3.56.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong Province","doi-asserted-by":"publisher","award":["2025CXPT115"],"award-info":[{"award-number":["2025CXPT115"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tstp20231248"],"award-info":[{"award-number":["tstp20231248"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2705805"],"award-info":[{"award-number":["2023YFC2705805"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ijgc.2026.104769","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T06:55:07Z","timestamp":1779173707000},"page":"104769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk stratification for single-agent chemoresistance in low-risk gestational trophoblastic neoplasia: a multicenter retrospective study"],"prefix":"10.1016","volume":"36","author":[{"given":"Wenna","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixian","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingsheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2330-3616","authenticated-orcid":false,"given":"Penglin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ijgc.2026.104769_bib1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/14737140.2023.2215438","article-title":"Management of trophoblastic tumors: review of evidence, current practice, and future directions","volume":"23","author":"Deleuze","year":"2023","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ijgc.2026.104769_bib2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ygyno.2022.12.020","article-title":"EMACO for treatment of gestational trophoblastic neoplasia: a multinational multicenter study","volume":"170","author":"Jareemit","year":"2023","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104769_bib3","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2020.04.704","article-title":"Gestational trophoblastic neoplasia lethality among Brazilian women: a retrospective national cohort study","volume":"158","author":"Freitas","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"suppl 1","key":"10.1016\/j.ijgc.2026.104769_bib4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ijgo.13877","article-title":"Diagnosis and management of gestational trophoblastic disease: 2021 update","volume":"155","author":"Ngan","year":"2021","journal-title":"Int J Gynecol Obstet"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104769_bib5","first-page":"e1","article-title":"Management of gestational trophoblastic disease","volume":"128","author":"Tidy","year":"2021","journal-title":"BJOG"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104769_bib6","article-title":"First-line chemotherapy in low-risk gestational trophoblastic neoplasia","volume":"2016","author":"Lawrie","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.ijgc.2026.104769_bib7","first-page":"CD012568","article-title":"Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia","author":"Mi","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104769_bib8","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1631\/jzus.B2100895","article-title":"Evaluation and simplification of risk factors in FIGO 2000 scoring system for gestational trophoblastic neoplasia: a 19-year retrospective analysis","volume":"23","author":"Weng","year":"2022","journal-title":"J Zhejiang Univ Sci B"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104769_bib9","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/ijc.34352","article-title":"PREDICT-GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?","volume":"152","author":"Parker","year":"2022","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.ijgc.2026.104769_bib10","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/annonc\/mdx211","article-title":"Can the FIGO 2000 scoring system for gestational trophoblastic neoplasia be simplified? A new retrospective analysis from a nationwide dataset","volume":"28","author":"Eysbouts","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijgc.2026.104769_bib11","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.938499","article-title":"Predicting chemotherapy resistance in gestational trophoblastic neoplasia: ratio of neutrophils, lymphocytes, monocytes, and platelets","volume":"28","author":"Winarno","year":"2022","journal-title":"Med Sci Monit"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104769_bib12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ygyno.2018.04.001","article-title":"Evaluation and suggestions for improving the FIGO 2000 staging criteria for gestational trophoblastic neoplasia: a ten-year review of 1420 patients","volume":"149","author":"Jiang","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104769_bib13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ygyno.2020.09.046","article-title":"Outcomes for relapsed versus resistant low risk gestational trophoblastic neoplasia following single-agent chemotherapy","volume":"159","author":"Jareemit","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104769_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1471-0528.2009.02420.x","article-title":"Prognosis of patients with relapsed and chemoresistant gestational trophoblastic neoplasia transferred to the Peking Union Medical College Hospital","volume":"117","author":"Feng","year":"2009","journal-title":"BJOG"},{"key":"10.1016\/j.ijgc.2026.104769_bib15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ygyno.2023.11.017","article-title":"PREDICT-GTN 2: Two-factor streamlined models match FIGO performance in gestational trophoblastic neoplasia","volume":"180","author":"Parker","year":"2024","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104769_bib16","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/IGC.0000000000000581","article-title":"Validation of the predictive value of modeled human chorionic gonadotrophin residual production in low-risk gestational trophoblastic neoplasia patients treated in NRG oncology\/gynecologic oncology Group-174 phase III trial","volume":"26","author":"You","year":"2016","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"10.1016\/j.ijgc.2026.104769_bib17","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/bjc.2013.123","article-title":"Early prediction of treatment resistance in low-risk gestational trophoblastic neoplasia using population kinetic modelling of hCG measurements","volume":"108","author":"You","year":"2013","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104769_bib18","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ygyno.2012.03.039","article-title":"Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy","volume":"125","author":"Chapman-Davis","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104769_bib19","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ygyno.2016.02.014","article-title":"Postmolar choriocarcinoma: an independent risk factor for chemotherapy resistance in low-risk gestational trophoblastic neoplasia","volume":"141","author":"Strohl","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ijgc.2026.104769_bib20","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S1470-2045(21)00262-X","article-title":"Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study","volume":"22","author":"Braga","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104769_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-5903-y","article-title":"Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer","volume":"19","author":"Hirahara","year":"2019","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104769_bib22","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1172\/JCI31537","article-title":"A cytokine-mediated link between innate immunity, inflammation, and cancer","volume":"117","author":"Lin","year":"2007","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104769_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-021-08521-0","article-title":"The platelet to lymphocyte ratio is a potential inflammatory marker predicting the effects of adjuvant chemotherapy in patients with stage II colorectal cancer","volume":"21","author":"Fu","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijgc.2026.104769_bib24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejogrb.2020.05.046","article-title":"Evaluation and influence of lung metastasis on patient outcome in gestational trophoblastic neoplasia: a 10-year study at a single institution","volume":"251","author":"Yu","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ijgc.2026.104769_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejca.2021.11.004","article-title":"The impact of pulmonary metastases on therapeutic response and prognosis in malignant gestational trophoblastic neoplasia patients: a retrospective cohort study","volume":"161","author":"Jiang","year":"2022","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.ijgc.2026.104769_bib26","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1111\/1471-0528.13622","article-title":"The influence of lung metastases on the clinical course of gestational trophoblastic neoplasia: a historical cohort study","volume":"123","author":"Vree","year":"2015","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104769_bib27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/1471-0528.16036","article-title":"Lung metastases in low-risk gestational trophoblastic neoplasia: a retrospective cohort study","volume":"127","author":"Frijstein","year":"2019","journal-title":"BJOG"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26003002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26003002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:47:16Z","timestamp":1785790036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X26003002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1048891X26003002"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104769","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk stratification for single-agent chemoresistance in low-risk gestational trophoblastic neoplasia: a multicenter retrospective study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104769"}}